mometasone furoate nasal spray / Merck (MSD), Generic mfg. 
Welcome,         Profile    Billing    Logout  

5 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mometasone furoate nasal spray / Generic mfg.
NCT05038202: Study of Bencycloquidium Bromide Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis

Active, not recruiting
4
450
RoW
Bencycloquidium Bromide Nasal Spray, BILITING, Mometasone Furoate Aqueous Nasal Spray, NASONEX
Yingu Pharmaceutical Co., Ltd
Allergic Rhinitis
04/24
06/24
2019-001532-65: Efficacy and Safety of sublingual immunotherapy with LAIS® Grass pollen tablets in patients with seasonal grass pollen-induced allergic rhinoconjunctivitis Efficacia e Sicurezza dell'immunoterapia sublinguale con compresse di di LAIS® Grass in pazienti con rinocongiuntivite allergica indotta dal polline di graminacee

Ongoing
3
264
Europe
LAIS Grass Sublingual Tablets, Desloratadina, Mometasone Furoato, Prednisone, Levocabastina, [LAIS Grass], [Desloratadina], [Mometasone Furoato], [Prednisone], [Levocabastina], Tablet, Film-coated tablet, Nasal spray, suspension, Eye drops, suspension, AERIUS - 5 MG 20 COMPRESSE RIVESTITE CON FILM USO ORALE, NASONEX - SPRAY NASALE 0.05% 140 EROGAZIONI 50 MCG/SPRUZZO, BF2 - 5 MG COMPRESSE 20 COMPRESSE, LEVOSTAB - 0.5 MG/ML SPRAY NASALE, SOSPENSIONE FLACONE 10 ML
LOFARMA S.P.A., Lofarma S.p.A.
seasonal grass pollen-induced allergic rhinoconjunctivitis rinocongiuntivite allergica stagionale indotta dal polline di graminacee, seasonal grass pollen-induced allergic rhinoconjunctivitis rinocongiuntivite allergica stagionale indotta dal polline di graminacee, Diseases [C] - Respiratory Tract Diseases [C08]
 
 
2021-004050-31: Efficacy and safety of the combination Mometasone furoate + Azelastine hydrochloride nasal spray in the treatment of seasonal allergic rhinitis

Not yet recruiting
3
700
Europe, RoW
Mometasone + Azelastine (50 + 140 mcg per actuation), Mometasone furoate nasal spray (50 mcg per actuation), Azelastine hydrochloride nasal spray (140 mcg per actuation), Test, Comparator 1, Comparator 2, Nasal spray
Lek Pharmaceuticals d.d., Lek Pharmaceuticals d.d.
Seasonal allergic rhinitis, Seasonal allergic rhinitis, Diseases [C] - Ear, nose and throat diseases [C09]
 
 
BiRCh, NCT06013241: A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

Recruiting
2
270
Europe, Canada, US, RoW
Brensocatib, INS1007, Placebo, Mometasone furoate nasal spray (MFNS)
Insmed Incorporated
Chronic Rhinosinusitis Without Nasal Polyps
08/25
09/25
2023-000362-34: Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis

Not yet recruiting
1
60
Canada
Mometasone furoate + azelastine hydrochloride 50 μg + 140 μg / dose nasal spray, Mometasone furoate 50 μg / dose nasal spray, Azelastine hydrochloride 140 μg / dose nasal spray, Nasal spray, suspension
Lek Pharmaceuticals d.d., Lek Pharmaceuticals d.d.
Seasonal Allergic Rhinitis, Hay fever, Diseases [C] - Immune System Diseases [C20]
 
 

Download Options